ELECTROCARDIOGRAPHIC AND HEMODYNAMIC CHANGES IN ANESTHETIZED DOGS UNDER THE INFLUENCE OF GLUCAGON

Z. Milanović ,
Z. Milanović

Institute of Physiology, Medical Faculty Prishtina , Kosovska Mitrovica , Kosovo*

A. Pavlović ,
A. Pavlović

Institute of Physiology, Medical Faculty Prishtina , Kosovska Mitrovica , Kosovo*

P. Jovanović ,
P. Jovanović

Institute of Physiology, Medical Faculty Prishtina , Kosovska Mitrovica , Kosovo*

B. Biševac ,
B. Biševac

Institute of Physiology, Medical Faculty Prishtina , Kosovska Mitrovica , Kosovo*

M. Miletić
M. Miletić

Institute of Physiology, Medical Faculty Prishtina , Kosovska Mitrovica , Kosovo*

Published: 01.01.2009.

Volume 37, Issue 1 (2009)

pp. 31-34;

https://doi.org/10.70949/pramed200901267M

Abstract

Scientific researches considering the effects of glucagon on cardiovascular system show that glucagon has a certain cardiostimulative potential. The fact that glucagon accomplishes its cardiostimulative effects by activating its own, highly specific glucagonic receptors is of most importance. That's the reason why we've wanted to give more details about the effects that glucagon has on cardiovascular system in terms of having more precise image of its effects on hemodynamics and changes which can be seen on electrocardiogram. The experiment included six dogs treated with intravenous glucagon injection. Electrocardiograph and hemodynamic parameters (middle arterial pressure, central venous pressure and heart st nd rd th th th th th frequency) have been recorded in 1 , 2 , 3 , 5 , 10 , 20 , 30 and 40 minute. Electrocardiograph and heart frequency have been recorded by continuous monitoring. Middle arterial pressure has been recorded through catheter placed into a. femoralis while central venous pressure has been recorded through central venous catheter placed into v. femoralis. Having received the intravenous injection, glucagon shows extremely positive chronotropic effect, followed by ephemeral increase of middle arterial pressure, while central venous pressure has a significant decrease. Having received intravenous injection, P-R, Q-Tand T-Pinterval have been significantly shorten.

Keywords

References

1.
Itoh F, Hodate K, Koyama S, Rose MT, Matsumoto M, Ozawa A, et al. Effects of heat exposure on adrenergic modulation of insulin and glucagon secretion in sheep. Endocr J. 48(2):193–8.
2.
Yamamoto H, Lee CE, Marcus JN. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 110:43–52.
3.
MG VP, JM E, X W. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res. 89:445–52.
4.
Vieira E, Liu YJ, Gylfe E. Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of glucagon-secreting mouse alpha-cells. Naunyn Schmiedebergs Arch Pharmacol. 369(2):179–83.
5.
Schiedermaier P, Goke B, Sauerbruch T. Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS. Am J Gastroenterol. 96(7):2218–24.
6.
Sauvadet A, Pecker F, Pavoline C. Inhibition of the sarcolemmal Ca pump in embryonic chick heart cells by miniglucagon. Cell Calcium. 18(1):76–85.
7.
Sauvadet A, Rohn T, Pecker F, Pavoine C. Synergistic action of glucagon and miniglucagon on Ca mobilization in cardiac cells. Circ Res. 78(1):102–9.
8.
Sato S, Tsuji MH, Okubo N, Nishimoto C, Naito H. Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model. J Toxicol Clin Toxicol. 33(4):337–42.
9.
Sato S, Tsuji MH, Okubo N, Naito H. Milrinone versus glucagon: Comparative hemodynamic effects in canine propranolol poisoning. J Toxicol Clin Toxicol. 32(3):277–89.
10.
Osaka T, Endo M, Yamakawa M, Inoue S. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympatho-adrenal system. Peptides. 26(9):1623–31.
11.
Farah A, Tuttle RJ. Pharmacological effects of glucagon. Pharmacol Exp Ther. 49(129).
12.
Boyd R, Ghosh A. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose. Emerg Med J. 20(3):266–7.
13.
14.
Barragan JM, Rodriguez RE, Blazquez E. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. Am J Physiol. 266(3 Pt 1).
15.
Wilkerson RD, Partlow DB, Pruet JK, Patterson CW. A possible mechanism of the antiarrhythmic action of glucagon. Eur J Pharmacol. 44(57).
16.
Manchester JH, Parmley WW, Matloff JM. Effects of glucagon on myocardial oxygen consumption and coronary blood flow in man and in dog. Circulation. 41(579).
17.
Sato S, Tsuji MH, Okubo N, Naito H. Milrinone versus glucagon: Comparative hemodynamic effects in canine propranolol poisoning. J Toxicol Clin Toxicol. 32(3):277–89.
18.
Sato S, Tsuji MH, Okubo N, Nishimoto C, Naito H. Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model. J Toxicol Clin Toxicol. 33(4):337–42.
19.
Lipski JI, Kaminsky DM, Donoso E, Friedberg CK. The electrophysiological properties of glucagon on the normal canine heart. Am J Physiol. 5(1107).
20.
Whitehouse FW, James TN. Chronotropic action of glucagon on the sinus node. Proc Soc Exp Biol Med. 122(823).

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by